Pappo AS - Search Results

1

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.

Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC, Bowman LC, Ma MK, Hoffer FA, Meyer WH, Pappo AS, Walter AW, Houghton PJ. Furman WL, et al. Among authors: pappo as. J Clin Oncol. 1999 Jun;17(6):1815-24. doi: 10.1200/JCO.1999.17.6.1815. J Clin Oncol. 1999. PMID: 10561220 Clinical Trial.

2

A phase I study of sulofenur in refractory pediatric malignant solid tumors.

Pratt CB, Bowman LC, Marina N, Pappo A, Avery L, Luo X, Meyer WH. Pratt CB, et al. Invest New Drugs. 1995;13(1):63-6. doi: 10.1007/BF02614222. Invest New Drugs. 1995. PMID: 7499110 Clinical Trial.

3

Biology and therapy of pediatric rhabdomyosarcoma.

Pappo AS, Shapiro DN, Crist WM, Maurer HM. Pappo AS, et al. J Clin Oncol. 1995 Aug;13(8):2123-39. doi: 10.1200/JCO.1995.13.8.2123. J Clin Oncol. 1995. PMID: 7636557 Review.

4

Malignant melanocytic lesions of unknown primary site in children and adolescents.

Pappo AS, Kuttesch JF, Kaste SC, Parham DM, Rao BN, Pratt CB. Pappo AS, et al. Med Pediatr Oncol. 1995 May;24(5):315-20. doi: 10.1002/mpo.2950240509. Med Pediatr Oncol. 1995. PMID: 7700184

5

Melanoma in children.

Pappo AS, Pratt CB. Pappo AS, et al. N Engl J Med. 1995 Jul 27;333(4):256-7. N Engl J Med. 1995. PMID: 7791847 No abstract available.

6

Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.

Regine WF, Fontanesi J, Kumar P, Ayers D, Bowman LC, Pappo AS, Coffey DH, Avery L, Rao BN, Kun LE. Regine WF, et al. Among authors: pappo as. Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):485-91. doi: 10.1016/0360-3016(94)00352-L. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852110

7

Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience.

Pappo AS, Fontanesi J, Luo X, Rao BN, Parham DM, Hurwitz C, Avery L, Pratt CB. Pappo AS, et al. J Clin Oncol. 1994 Nov;12(11):2360-6. doi: 10.1200/JCO.1994.12.11.2360. J Clin Oncol. 1994. PMID: 7964951

8

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.

Marina NM, Shema SJ, Bowman LC, Rodman J, Douglass EC, Furman WL, Pappo A, Santana VM, Hudson M, Meyer WH, et al. Marina NM, et al. Med Pediatr Oncol. 1994;23(4):328-34. doi: 10.1002/mpo.2950230403. Med Pediatr Oncol. 1994. PMID: 8058003

9

Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma.

Pappo AS, Douglass EC, Meyer WH, Marina N, Parham DM. Pappo AS, et al. Hum Pathol. 1993 Aug;24(8):880-5. doi: 10.1016/0046-8177(93)90138-7. Hum Pathol. 1993. PMID: 8375858

10

Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.

Pappo AS, Crist WM, Kuttesch J, Rowe S, Ashmun RA, Maurer HM, Newton WA, Asmar L, Luo X, Shapiro DN. Pappo AS, et al. J Clin Oncol. 1993 Oct;11(10):1901-5. doi: 10.1200/JCO.1993.11.10.1901. J Clin Oncol. 1993. PMID: 8410116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page